Sharp SY - Search Results

1

Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.

Kelland LR, Sharp SY, O'Neill CF, Raynaud FI, Beale PJ, Judson IR. Kelland LR, et al. Among authors: sharp sy. J Inorg Biochem. 1999 Oct;77(1-2):111-5. J Inorg Biochem. 1999. PMID: 10626362 Review.

2

Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.

Sharp SY, Mistry P, Valenti MR, Bryant AP, Kelland LR. Sharp SY, et al. Cancer Chemother Pharmacol. 1994;35(2):137-43. doi: 10.1007/BF00686636. Cancer Chemother Pharmacol. 1994. PMID: 7987990

3

Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.

Sharp SY, Rowlands MG, Jarman M, Kelland LR. Sharp SY, et al. Br J Cancer. 1994 Sep;70(3):409-14. doi: 10.1038/bjc.1994.319. Br J Cancer. 1994. PMID: 8080723 Free PMC article.

4

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.

Holford J, Sharp SY, Murrer BA, Abrams M, Kelland LR. Holford J, et al. Among authors: sharp sy. Br J Cancer. 1998;77(3):366-73. doi: 10.1038/bjc.1998.59. Br J Cancer. 1998. PMID: 9472630 Free PMC article.

5

Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.

Sharp SY, Smith V, Hobbs S, Kelland LR. Sharp SY, et al. Br J Cancer. 1998 Jul;78(2):175-80. doi: 10.1038/bjc.1998.461. Br J Cancer. 1998. PMID: 9683290 Free PMC article.

6

Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.

Sharp SY, Rogers PM, Kelland LR. Sharp SY, et al. Clin Cancer Res. 1995 Sep;1(9):981-9. Clin Cancer Res. 1995. PMID: 9816070

7

DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90.

Kelland LR, Sharp SY, Rogers PM, Myers TG, Workman P. Kelland LR, et al. Among authors: sharp sy. J Natl Cancer Inst. 1999 Nov 17;91(22):1940-9. doi: 10.1093/jnci/91.22.1940. J Natl Cancer Inst. 1999. PMID: 10564678

8

A molecular cytogenetic approach to studying platinum resistance.

Hiorns LR, Seckl MJ, Paradinas F, Sharp SY, Skelton LA, Brunstrom G, Newlands ES, Kelland LR, Leyland-Jones B. Hiorns LR, et al. Among authors: sharp sy. J Inorg Biochem. 1999 Oct;77(1-2):95-104. doi: 10.1016/s0162-0134(99)00140-3. J Inorg Biochem. 1999. PMID: 10626360

9

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma.

Beale PJ, Rogers P, Boxall F, Sharp SY, Kelland LR. Beale PJ, et al. Among authors: sharp sy. Br J Cancer. 2000 Jan;82(2):436-40. doi: 10.1054/bjoc.1999.0939. Br J Cancer. 2000. PMID: 10646901 Free PMC article.

10

Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines.

Holford J, Beale PJ, Boxall FE, Sharp SY, Kelland LR. Holford J, et al. Among authors: sharp sy. Eur J Cancer. 2000 Oct;36(15):1984-90. doi: 10.1016/s0959-8049(00)00192-1. Eur J Cancer. 2000. PMID: 11000581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters